There are contraindications! Be sure to consult your doctor before taking any medication!

Longacef

Longacef - Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Longacef is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. The antibacterial effect of Longacef results from inhibition of mucopeptide synthesis in the bacterial cell wall.

Indication: For use in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: (1) uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis, (2) otitis media caused by Haemophilus influenzae (beta-lactamase positive and negative strains), Moraxella catarrhalis (most of which are beta-lactamase positive), and S. pyogenes, (3) pharyngitis and tonsillitis caused by S. pyogenes, (4) acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae (beta-lactamase positive and negative strains), and (5) uncomplicated gonorrhea (cervical/urethral) caused by Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains).

Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products:

• Cefixime

Longacef available forms, composition, doses:

• N/A

Longacef destination | category:

• Human:
• Cephalosporins third-generation

Indications and usages, anatomical therapeutic chemical and diseases classification codes:

• J01DD08 - Cefixime

Pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers:

• Leti Laboratorios